| 注册
首页|期刊导航|哈尔滨医药|手法复位联合药物治疗良性阵发性位置性眩晕患者的临床疗效分析

手法复位联合药物治疗良性阵发性位置性眩晕患者的临床疗效分析

邹达良 周映彤 黎罗明 冯欣 李华文

哈尔滨医药2016,Vol.36Issue(z1):43-44,45,3.
哈尔滨医药2016,Vol.36Issue(z1):43-44,45,3.

手法复位联合药物治疗良性阵发性位置性眩晕患者的临床疗效分析

Manual Reduction Combined Medication BPP the Patient's Clinical Curative Effect Analysis

邹达良 1周映彤 1黎罗明 1冯欣 1李华文1

作者信息

  • 1. 中山市陈星海医院神经内科,广东中山 528415
  • 折叠

摘要

Abstract

Objective To analyze the clinical curative effect of drugs combined with manipulative reduction for the treatment of various types of otolith in patients with benign paroxysmal positional vertigo.Methods A total of 774 cases with otolith positional vertigo patients in our hospital from September 1,2013 to August 31,2015 were selected,all patients were randomly divided into drug group(N=385)and combined group(N=389)according to the order of admission.The drug group only received drug treatment of otolith disorders,including betahistine,Sibeline capsule and microcirculation drugs,the combination group was performed Epley and Barbecue manipulative reduction on the basis of drug treatment.The clinical effect of two groups of patients for 1 weeks,1 months and the incidence of adverse reactions and recurrence rate were compared.Results 1 weeks,1 months after treatment,the combina-tion group’s effective rate was 93.2%and 93.7%,significantly higher than the drug group 87.3%and 82.9%,the difference was sta-tistically significant,P<0.05.The combined treatment group otolith disease recurrence rate was 8.4% after 1 month,significantly low-er than the drug group’s recurrence rate was 17.6%,the difference is statistically significant (P<0.05).Conclusion According to the different types of otolith disorders using drugs combined with manipulative reduction has better clinical efficacy and less adverse reaction.It is safe and effective,worthy of clinical use.

关键词

联合/手法复位/耳石症/良性阵发性位置性眩晕

Key words

Joint/Manipulation reduction/Otolith disease/Benign positional vertigo

分类

医药卫生

引用本文复制引用

邹达良,周映彤,黎罗明,冯欣,李华文..手法复位联合药物治疗良性阵发性位置性眩晕患者的临床疗效分析[J].哈尔滨医药,2016,36(z1):43-44,45,3.

哈尔滨医药

1001-8131

访问量0
|
下载量0
段落导航相关论文